The founder of five biotech companies including HDT Bio Corp., Compliment Corp., and PAI Life Sciences Inc.
Member of the board of directors of two biotech companies in Seattle.
A scientific advisor for vaccine and global health institutes.
He has two affiliate professorships at the University of Washington in the School of Medicine and in Global Health.
Darrick’s current research includes immune stimulants and vaccine formulations, structure-based protein design and immune oncology.
He is inventor on over 160 patents and patent applications and has authored over 100 publications.
More than $150 million of raised capital.
He went company to IPO.
Conducted more than 50 preclinical trials of the developed technologies.
Five IND statuses for technologies were obtained and clinical trials were conducted.
Two drugs have been brought to the market.